ABIGAIL RYAN: Open Payments
NPI 1306503362 · FOUNTAIN HILL, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,326 in 12 payments from 6 companies in 2025. Trend: 2023 $643 · 2024 $935 · 2025 $1,326
Food & beverage: $811Travel & lodging: $514
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 4 | $829 |
| Gilead Sciences, Inc. | 1 | $125 |
| Novo Nordisk Inc | 1 | $125 |
| Ardelyx, Inc. | 1 | $109 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $76 |
| ABBVIE INC. | 1 | $63 |
Products named: General - Therapies, Livdelzi, Wegovy, IBSRELA, XIFAXAN, LINZESS.
Industry payments across PA — which companies pay providers there.
